Skip to content

Roche to halt HIV drug research

Kivexa restored to first-line status in final British guidelines - but with cautions

Anti-HIV treatment as successful in South Africa as Switzerland - but starting treatment late is costing lives

'ART as prevention tool' policy announced for British Columbia

The Lancet: HIV is a global disaster

Important changes to nevirapine dosing advice made by FDA

Fatty liver in patients with HIV associated with metabolic abnormalities

Simple, cheap test an accurate measure of hardening of the arteries in patients with HIV

Untreated HIV infection may facilitate rifampicin-resistant and multi-drug-resistant TB strains